Woodward D F, Johnson L, Spada C, Chen J
Discovery Research, Allergan Eye and Skin Care Group, Irvine, California.
J Ocul Pharmacol. 1986 Summer;2(3):275-8. doi: 10.1089/jop.1986.2.275.
Histamine-induced ocular surface redness was virtually abolished by a combination of cimetidine (H2-receptor antagonist) and pyrilamine (H1-receptor antagonist), whereas either antagonist administered alone produced no significant reduction. It appears that combined H1- and H2-antagonist therapy is required for effective blockade of ocular responses to histamine that involve both receptor subtypes.